| 000 | 01736 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250516023150.0 | ||
| 264 | 0 | _c20110527 | |
| 008 | 201105s 0 0 eng d | ||
| 022 | _a1527-7755 | ||
| 024 | 7 |
_a10.1200/JCO.2010.33.8087 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHerchenhorn, Daniel | |
| 245 | 0 | 0 |
_aTargeting epidermal growth factor receptor to optimize chemoradiotherapy in locally advanced head and neck cancer: has biology been taken into account? _h[electronic resource] |
| 260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cApr 2011 |
||
| 300 |
_ae283-4; author reply e285-7 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdrug therapy |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
| 650 | 0 | 4 | _aGefitinib |
| 650 | 0 | 4 |
_aHead and Neck Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aQuinazolines _xadministration & dosage |
| 650 | 0 | 4 | _aRadiation Tolerance |
| 650 | 0 | 4 | _aRadiotherapy, Adjuvant |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aFerreira, Carlos G | |
| 773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 29 _gno. 10 _gp. e283-4; author reply e285-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.2010.33.8087 _zAvailable from publisher's website |
| 999 |
_c20579204 _d20579204 |
||